High-content CRISPR screening in tumor immunology

Erin A Holcomb1,2, Ashley N Pearson1,2, Kassidy M Jungles2,3,4

  • 1Graduate Program in Immunology, School of Medicine, University of Michigan, Ann Arbor, MI, United States.

Frontiers in Immunology
|December 8, 2022
PubMed
Summary

High-content CRISPR screens link genetic changes to cell behaviors, revealing immune regulators in cancer and viral infections. These advanced methods are key to understanding tumor immunology and discovering new cancer therapies.

Related Concept Videos